ÂÜÀòÂÒÂ×

Darin Hildebrandt began their career in 2006 as a Senior Research Associate II at Achaogen. Darin then moved to REVOLUTION Medicines in 2019 as a Chemist. In 2020, they became a Contract Chemist at Nurix Therapeutics and most recently in 2021, they took on the role of Associate Scientist at Lycia Therapeutics.

Darin Hildebrandt attended University of California, Santa Barbara from 1996 to 1999 and obtained a Bachelor of Science in Pharmacology. Darin then attended San Francisco State University from 2006 to present, but did not obtain a Master of Science in Organic Chemistry.